BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25433838)

  • 21. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
    Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
    Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of genomic amplification of the human telomerase RNA component gene in the screening of cervical lesions].
    Jiang J; Tu Z; Zhang G; Li JR; Zhao LJ; Zhao C; Cui SH; Li XP; Chen Z; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):849-53. PubMed ID: 19087570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different amplification patterns of 3q26 and 5p15 regions in cervical intraepithelial neoplasia and cervical cancer.
    Kudela E; Visnovsky J; Balharek T; Farkasova A; Zubor P; Plank L; Danko J
    Ann Diagn Pathol; 2018 Aug; 35():16-20. PubMed ID: 30072014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of human telomerase RNA component gene by fluorescent in situ hybridization for screening of cervical lesions].
    Gao L; Zhu Y; Liu SP; Gao Y; Zhu MH
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):104-7. PubMed ID: 21426806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human telomerase RNA gene (TERC) gain and polysomy of chromosome 3 in cervicovaginal liquid-based pap preparations: a fluorescence in situ hybridization study.
    Sui W; Ou M; Chen J; Yu J; Zhang Y; Lan H; Huang H; Dai Y
    Eur J Gynaecol Oncol; 2010; 31(4):375-9. PubMed ID: 20882876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Role of the Detection of Human Telomerase RNA Component Gene Amplification by Fluorescence in situ Hybridization on Liquid-Based Cervical Samples: Comparison with Human Papillomavirus-DNA Testing and Histopathology.
    Zappacosta R; Ianieri MM; Buca D; Repetti E; Ricciardulli A; Liberati M
    Acta Cytol; 2015; 59(4):345-54. PubMed ID: 26343271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III.
    Xiang L; Yang H; Li J; Wu X; Zhou X
    Diagn Cytopathol; 2012 Oct; 40(10):849-55. PubMed ID: 21381227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.
    Zhang Y; Wang X; Ma L; Wang Z; Hu L
    J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):368-71. PubMed ID: 19513624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia.
    Takac I; Arko D; Kodric T; Poljak M; Zagorac A; Erjavec-Skerget A; Kokalj-Vokac N
    J Int Med Res; 2009; 37(5):1588-95. PubMed ID: 19930867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.
    Heselmeyer-Haddad K; Janz V; Castle PE; Chaudhri N; White N; Wilber K; Morrison LE; Auer G; Burroughs FH; Sherman ME; Ried T
    Am J Pathol; 2003 Oct; 163(4):1405-16. PubMed ID: 14507648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions.
    Kokalj-Vokac N; Kodric T; Erjavec-Skerget A; Zagorac A; Takac I
    Cancer Genet Cytogenet; 2009 Nov; 195(1):19-22. PubMed ID: 19837263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic amplification of hTERC in paraffin-embedded tissues of cervical intraepithelial neoplasia and invasive cancer.
    He C; Xu C; Xu M; Yuan Y; Sun Y; Zhao H; Zhang X
    Int J Gynecol Pathol; 2012 May; 31(3):280-5. PubMed ID: 22498947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Annunziata C; Pezzuto F; Greggi S; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
    Int J Cancer; 2018 Sep; 143(5):1153-1161. PubMed ID: 29603728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [hTERC gene amplification and expression of human papillomavirus in cervical carcinogenesis].
    Li SH; Liu LL; Ma HX; Wang QH; Bai W
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):121-2. PubMed ID: 22455890
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical application of telomerase RNA component gene amplification assay in cervical lesions.].
    Jiang J; Wei LH; Wu RF; Zhang G; Wulan N; Li JR; Li YB; Tu Z; Zhou YQ; Zhao Y; Chen Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):883-6. PubMed ID: 20193412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression.
    Zhu Y; Han Y; Tian T; Su P; Jin G; Chen J; Cao Y
    Pathol Res Pract; 2018 Mar; 214(3):374-379. PubMed ID: 29487007
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.